Global /China /Healthcare /Drug Manufacturers - General /000153

Anhui Fengyuan Pharmaceutical Co., Ltd.

000153

• SHE: 000153 • Delayed

6.45CNY -0.3%

0.9531 USD

As of 17 June 2026, Anhui Fengyuan Pharmaceutical Co., Ltd. has a market cap of $444.92M USD, ranking #15984 globally and #5017 in China. It ranks #1431 in the Healthcare sector, and #521 in the Drug Manufacturers - General industry.

Global Rank

15984

Country Rank

5017

Sector Rank

1431

Industry Rank

521

Key Stats

Market Cap

$444.92MUSD

3.01B CNY

Enterprise Value

$551.02MUSD

3.73B CNY

Revenue (TTM)

$570.95MUSD

3.86B CNY

EBITDA (TTM)

$45.44MUSD

307.53M CNY

Net Income (TTM)

$14.71MUSD

99.42M CNY

EBITDA Margin

Profit Margin

2.6%

PE Ratio

30.2

PS Ratio

0.8

PB Ratio

1.4

EV/EBITDA

11.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Tianle Ru open_in_new

Employees

4,542

Founded

1997

Website

bbcayy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-0.3%	0.6%	-1.4%	-3.3%	3.2%	15%	-11%	14%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000153 安徽丰原药业股份有限公司 Class A ISIN: CNE0000014X5 Shares Out.: Shares Outstanding: 464.686M¹ Shares Float: 323.21M² TV: TradingView: SZSE: 000153 SA: Stock Analysis: SHE: 000153 YF: Yahoo Finance: 000153.SZ GF: Google Finance: SHE: 000153 BA: Barron's: 000153 MS: Morningstar: XSHE: 000153	6.45 CNY	TV: TradingView: SZSE: 000153 SA: Stock Analysis: SHE: 000153 YF: Yahoo Finance: 000153.SZ GF: Google Finance: SHE: 000153 BA: Barron's: 000153 MS: Morningstar: XSHE: 000153

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Anhui Fengyuan Pharmaceutical Co., Ltd.

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$54.0B 364.89B CNY 12K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.78B 336.36B CNY 11K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.53B 223.48B HKD 6K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.81B 147.32B HKD 4K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.02B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 171K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 123K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 81K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 72K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 65K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 62K%	20.5	Switzerland

chevron_leftBack